By REUTERS
The embattled $40 billion pharmaceuticals company tried – but failed – to quell concerns about its convoluted dealings with distributors.
Published: October 27, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1LRVFUT
from WordPress http://ift.tt/1NwlFIn
via Hadi Aboukhater
No comments:
Post a Comment